You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 334 Phase I study of safety and activity of personalized neoantigen-based vaccines in combination with tumor treating fields for newly diagnosed glioblastoma patients

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials Completed
334 Phase I study of safety and activity of personalized neoantigen-based vaccines in combination with tumor treating fields for newly diagnosed glioblastoma patients
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to September 2024

AbstractFullPdf
Nov 2021322022
Dec 2021116011
Jan 20228809
Feb 202288014
Mar 202225809
Apr 20225808
May 202244013
Jun 202258013
Jul 202286011
Aug 20226205
Sep 20226207
Oct 202216205
Nov 20226206
Dec 20226404
Jan 20234006
Feb 20234206
Mar 20231604
Apr 20235006
May 20233004
Jun 20231203
Jul 202332010
Aug 20232208
Sep 20232403
Oct 20233807
Nov 20236603
Dec 20237804
Jan 20242602
Feb 202454010
Mar 20247809
Apr 202440013
May 20245603
Jun 20243707
Jul 20244406
Aug 20242903
Sep 202436011
Total23800265